Litcius/Paper detail

Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

Anne Sophie Sølling, Torben Harsløf, Niklas Rye Jørgensen, Bente Langdahl

2022Osteoporosis International25 citationsDOI

Topics & Concepts

DenosumabRANKLMedicineBone resorptionDiscontinuationResorptionBone Density Conservation AgentsInternal medicineEndocrinologyRheumatologyOsteoclastCancer researchOsteoporosisReceptorBone mineralActivator (genetics)Bone Metabolism and DiseasesBone health and osteoporosis researchBone health and treatments
Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption | Litcius